Socialist Party deputy Juan Luis Castro has revealed his growing suspicions regarding possible price-fixing between several laboratories across the country, representing much of Chile’s pharmaceutical industry. The congressman has pointed to a 42% increase in the prices of 16 of the country’s 20 most-used medications, all during a short period between 2015 and 2016.
Castro, who is a member of the Health Commission, believes that “this increase in the price of 20 of Chile’s most consumed medications is a low blow to the middle class and all popular sectors, since it implies increases in common remedies such as paracetamol, ibuprofen, loratadine, salbutamol and many other daily-use substances.”
Castro announced his intentions to “take these findings to the Public Health Institute and the National Economic Prosecutor, because there probably are signs of collusion, agreements to raise prices in their products, as has already been seen with drugstores and which may now be occurring between laboratories.”
Full Content: Terra
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Canadian Watchdog Launches In-Depth Study of Airline Industry
Jul 29, 2024 by
CPI
Hewlett Packard Nears EU Approval for $14 Billion Juniper Networks Deal
Jul 29, 2024 by
CPI
Volkswagen and Rivian Joint Venture Cleared by German Competition Authority
Jul 29, 2024 by
CPI
Mauritius Launches Antitrust Probe into Pharmaceutical Sector
Jul 29, 2024 by
CPI
DOJ Pushes for TikTok Sale Amid National Security Concerns
Jul 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Trade & Antitrust
Jul 26, 2024 by
CPI
What is Wrong with the WTO Discipline on Subsidies?
Jul 26, 2024 by
CPI
The Abiding Tension Between Trade Remedy Law and Antitrust
Jul 26, 2024 by
CPI
Trade and Antitrust: An End to Isolationism
Jul 26, 2024 by
CPI
International Trade Law and Domestic Regulation of Generative Artificial Intelligence: Divergent Approaches?
Jul 26, 2024 by
CPI